Therapeutic Asset Ratings
748 results matching 1 filter
129,767 assets · 8,707 sponsors · 3,128 indications
Methodology v0.2
Filters
1
Highest Rated
Advanced Phase
Alphabetical
Recently Updated
Asset
Sponsor
Phase
Rating
Gardasil 9 Vaccine
Myelodysplastic Syndrome
Vastra Gotaland Region
P2
CCC
(51)
had5-hpv vaccine
Head And Neck Cancer
ImmunityBio, Inc.
P2
CCC
(51)
LISTERIA MONOCYTOGENESSTRAIN STRAIN CRS-207
Pancreatic Neoplasm
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
P2
CCC
(51)
MODERNA COVID-19 VACCINE RNA
Multiple Sclerosis
Griffin Hospital
P2
CCC
(51)
muc1 peptide-poly-iclc vaccine
Colorectal Carcinoma
National Cancer Institute (NCI)
P2
CCC
(51)
Muc-1 Peptide Vaccine
Colorectal Carcinoma
National Cancer Institute (NCI)
P2
CCC
(51)
Neoantigen Dendritic Cell Vaccine
Colorectal Carcinoma
National Cancer Centre, Singapore
P2
CCC
(51)
Neoantigen Dendritic Cell Vaccine
Liver Metastases
National Cancer Centre, Singapore
P2
CCC
(51)
ose2101
Metastatic Malignant Neoplasm
GERCOR - Multidisciplinary Oncology Cooperative Group
P2
CCC
(51)
Ptvg-Ar
Metastatic Malignant Neoplasm
University of Wisconsin, Madison
P2
CCC
(51)
Ptvg-Hp
Metastatic Malignant Neoplasm
University of Wisconsin, Madison
P2
CCC
(51)
Ucpvax
Glioblastoma
Centre Hospitalier Universitaire de Besancon
P2
CCC
(51)
Moderna Bivalent Mrna Vaccine
Plasma Cell Myeloma
Monash University
P3
CCC
(50)
Pfizer Bivalent Covid-19 Vaccine
Plasma Cell Myeloma
Monash University
P3
CCC
(50)
Autogene Cevumeran
Colorectal Cancer
BioNTech SE
P2
CCC
(50)
Dpx-Survivac
Ovarian Cancer
ImmunoVaccine Technologies, Inc. (IMV Inc.)
P2
CCC
(50)
Multi-Peptide Cmv-Modified Vaccinia Ankara Vaccine
Acute Myeloid Leukemia
City of Hope Medical Center
P2
CCC
(50)
Ny-Eso-1 Peptide Vaccine
Ovarian Cancer
Georgetown University
P2
CCC
(50)
Pumvc3-Higfbp-2 Multi-Epitope Plasmid Dna Vaccine
Fallopian Tube Carcinoma
University of Washington
P2
CCC
(50)
Pumvc3-Higfbp-2 Multi-Epitope Plasmid Dna Vaccine
Primary Peritoneal Carcinoma
University of Washington
P2
CCC
(50)
tg01
Non-Small Cell Lung Carcinoma
Georgetown University
P2
CCC
(50)
Tozinameran
Juvenile Dermatomyositis
National Institute of Allergy and Infectious Diseases (NIAID)
P2
CCC
(50)
Tozinameran
Juvenile Idiopathic Arthritis
National Institute of Allergy and Infectious Diseases (NIAID)
P2
CCC
(50)
Tozinameran
Multiple Sclerosis
National Institute of Allergy and Infectious Diseases (NIAID)
P2
CCC
(50)
Tozinameran
Pediatric Multiple Sclerosis
National Institute of Allergy and Infectious Diseases (NIAID)
P2
CCC
(50)
Showing 326 to 350 of 748 assets
Previous
Page 14 of 30
Next